“Ambulatory infusion centers, home infusion providers, and specialty pharmacies serve patients who often have few alternative care settings. When the revenue cycle fails, or when leadership lacks data to make sound decisions about payer contracting or site viability, the downstream effect isn’t an abstract financial loss, it’s a care delivery constraint. That proximity to what happens clinically is what drew me to this sector and what continues to define how SolisRx engages with its clients.”
— Chris Hilger
About Chris
Chris Hilger founded SolisRx in 2023 to solve a problem he had seen from every angle during his career in healthcare data: providers generate enormous amounts of clinical and financial data but lack the analytical infrastructure to act on it in time to matter.
His work is advisory at its core. He works directly with multi-site infusion operators, PE sponsors, and healthcare executives to help connect fragmented data, identify the root causes of revenue leakage, and build monitoring systems that prevent those problems from recurring.
Many of our engagements aren’t public but the most visible example of SolisRx's work is FlexCare Infusion Centers, a large ambulatory infusion organization where an initial revenue cycle diagnostic evolved into a multi-year analytics infrastructure engagement. SolisRx provided ongoing analytics and intelligence services, including the diligence-readiness work that supported FlexCare’s acquisition in spring 2025.
Chris was Director of Data Platforms at Kalderos (Bain Capital Ventures), where he rebuilt the company’s data infrastructure on a modern cloud-native architecture and stood up the analytics team. He led go-to-market at Centaur Labs (Y Combinator), structuring the clinical data pipelines behind medical AI training systems.
Chris holds a Master’s in Health Data Science from the Harvard T.H. Chan School of Public Health. He is an active member of NICA and NHIA and speaks on infusion analytics, intake workflow visibility, and automation.
His work was featured in Bourne Partners’ 2025 Infusion Market Update, an annual publication widely read by infusion sector investment bankers, PE sponsors, and strategic acquirers.
Chris continues to work closely with operators and private equity sponsors to drive sustainable growth through better data.
